BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3240518)

  • 21. Mechanism-based inhibition of human leukocyte elastase and cathepsin G by substituted dihydrouracils.
    Groutas WC; Huang H; Epp JB; Venkataraman R; McClenahan JJ; Tagusagawa F
    Biochim Biophys Acta; 1994 Nov; 1227(3):130-6. PubMed ID: 7986820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of elastase in the digestion of E. coli proteins by human polymorphonuclear leukocytes. I. Experiments in vitro.
    Janoff A; Blondin J
    Proc Soc Exp Biol Med; 1974 Apr; 145(4):1427-30. PubMed ID: 4597281
    [No Abstract]   [Full Text] [Related]  

  • 23. Degradation of a novel tripeptide, tert-butoxycarbonyl-Tyr-Leu-Val-CH2Cl, with inhibitory effect on human leukocyte elastase in aqueous solution and in biological fluids.
    Tokumitsu H; Fukumori Y; Tsuda Y; Okada Y; Kasuya F; Igarashi K; Fukui M
    Chem Pharm Bull (Tokyo); 1997 Nov; 45(11):1845-50. PubMed ID: 9396162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity.
    Morrison HM; Welgus HG; Stockley RA; Burnett D; Campbell EJ
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):263-9. PubMed ID: 2310584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-aminoxy acids as building blocks for the oxime and hydroxylamine pseudopeptide links. Application to the synthesis of human elastase inhibitors.
    Vanderesse R; Thevenet L; Marraud M; Boggetto N; Reboud M; Corbier C
    J Pept Sci; 2003 May; 9(5):282-99. PubMed ID: 12803495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-activity studies of fluoroketone inhibitors of alpha-lytic protease and human leukocyte elastase.
    Govardhan CP; Abeles RH
    Arch Biochem Biophys; 1990 Jul; 280(1):137-46. PubMed ID: 2353815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel potential mechanism-based inhibitors of human leukocyte elastase and cathepsin G: derivatives of isothiazolidin-3-one.
    Groutas WC; Chong LS; Venkataraman R
    Biochem Biophys Res Commun; 1993 Dec; 197(2):730-9. PubMed ID: 8267609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human leukocyte elastase. 4. Selection of a substituted cephalosporin (L-658,758) as a topical aerosol.
    Finke PE; Shah SK; Ashe BM; Ball RG; Blacklock TJ; Bonney RJ; Brause KA; Chandler GO; Cotton M; Davies P
    J Med Chem; 1992 Oct; 35(21):3731-44. PubMed ID: 1433188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Irreversible inhibition of serine proteases by peptide derivatives of (alpha-aminoalkyl)phosphonate diphenyl esters.
    Oleksyszyn J; Powers JC
    Biochemistry; 1991 Jan; 30(2):485-93. PubMed ID: 1988040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cephalosporin antibiotics can be modified to inhibit human leukocyte elastase.
    Doherty JB; Ashe BM; Argenbright LW; Barker PL; Bonney RJ; Chandler GO; Dahlgren ME; Dorn CP; Finke PE; Firestone RA
    Nature; 1986 Jul 10-16; 322(6075):192-4. PubMed ID: 3636599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of human leucocyte elastase and chymotrypsin-like protease by elastatinal and chymostatin.
    Feinstein G; Malemud CJ; Janoff A
    Biochim Biophys Acta; 1976 May; 429(3):925-32. PubMed ID: 1083745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism for slow-binding inhibition of human leukocyte elastase by valine-derived benzoxazinones.
    Stein RL; Strimpler AM; Viscarello BR; Wildonger RA; Mauger RC; Trainor DA
    Biochemistry; 1987 Jun; 26(13):4126-30. PubMed ID: 3651441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments.
    Lafuma C; Frisdal E; Harf A; Robert L; Hornebeck W
    Eur Respir J; 1991 Sep; 4(8):1004-9. PubMed ID: 1783073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acyloxybenzyl halides, inhibitors of elastases.
    Vilain AC; Okochi V; Vergely I; Reboud-Ravaux M; Mazaleyrat JP; Wakselman M
    Biochim Biophys Acta; 1991 Feb; 1076(3):401-5. PubMed ID: 2001388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of different elastase inhibitors on leukocyte elastase pre-adsorbed to elastin.
    Hornebeck W; Schnebli HP
    Hoppe Seylers Z Physiol Chem; 1982 Apr; 363(4):455-8. PubMed ID: 6918355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes.
    Janoff A; Scherer J
    J Exp Med; 1968 Nov; 128(5):1137-55. PubMed ID: 5303065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivatives of 3-alkyl-N-hydroxysuccinimide: probing the effect of structure on bioactivity toward human leukocyte elastase.
    Groutas WC; Brubaker MJ; Chong LS; Epp JB; Huang H; Keller CE; McClenahan JJ; Givens RS; Singh R; Zandler ME
    Drug Des Discov; 1994 Feb; 11(2):149-57. PubMed ID: 8075302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic inhibitors of human leukocyte elastase Part 1--Sulphated polysaccharides.
    Lentini A; Ternai B; Ghosh P
    Biochem Int; 1985 Feb; 10(2):221-32. PubMed ID: 2581575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective effect of oleoyl peptide conjugates against elastolysis by neutrophil elastase and kappa elastin-induced monocyte chemotaxis.
    Rasoamanantena P; Moczar E; Robert L; Wei SM; Godeau G; Hornebeck W
    Am J Respir Cell Mol Biol; 1993 Jan; 8(1):50-5. PubMed ID: 8417756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of some types of inflammatory damage using AA 231-1, a fluorinated beta-lactam.
    Reboud-Ravaux M; Vergely I; Maillard J; Favreau C; Kobaiter R; Joyeau R; Wakselman M
    Drugs Exp Clin Res; 1992; 18(5):159-62. PubMed ID: 1490431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.